Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic

Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic

Saved in:
Bibliographic Details
Published in:The lancet oncology Vol. 21; no. 5; pp. 624 - 627
Main Authors: de Paula, Bruno H R, Araújo, Indiara, Bandeira, Lívia, Barreto, Nathália M P B, Doherty, Gary J
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01-05-2020
Elsevier Limited
Subjects:
Clinical trials
Clinical Trials as Topic
Colombia
Comment
Coronavirus Infections - epidemiology
Coronaviruses
COVID-19
Government Agencies
Humans
Neoplasms - therapy
Norway
Pandemics
Patients
Pneumonia, Viral - epidemiology
United Kingdom
United States
United States Food and Drug Administration
Colombia
United Kingdom
Norway
United States
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1470-2045
1474-5488
DOI:10.1016/S1470-2045(20)30226-6